Caplin Point Laboratories Limited Stock NSE India S.E.
Equities
CAPLIPOINT
INE475E01026
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,312 INR | -0.36% | +1.43% | -3.28% |
Apr. 16 | Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution | MT |
Mar. 28 | Caplin Point Unit Receives US FDA Nod for Eye Treatment Medication | MT |
Sales 2024 * | 16.88B 202M | Sales 2025 * | 19.22B 230M | Capitalization | 99.87B 1.2B |
---|---|---|---|---|---|
Net income 2024 * | 4.56B 54.7M | Net income 2025 * | 4.68B 56.18M | EV / Sales 2024 * | 5.92 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.2 x |
P/E ratio 2024 * |
21.9
x | P/E ratio 2025 * |
20.4
x | Employees | 1,642 |
Yield 2024 * |
0.24% | Yield 2025 * |
0.26% | Free-Float | 25.33% |
Latest transcript on Caplin Point Laboratories Limited
1 day | -0.36% | ||
1 week | +1.43% | ||
Current month | -0.28% | ||
1 month | +2.79% | ||
3 months | -11.20% | ||
6 months | +22.30% | ||
Current year | -3.28% |
Managers | Title | Age | Since |
---|---|---|---|
Sridhar Ganesan
CEO | Chief Executive Officer | 69 | 15-03-27 |
D. Muralidharan
DFI | Director of Finance/CFO | - | 16-02-18 |
Anto V.
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | - | |
Chief Operating Officer | - | 10-11-30 | |
Sridhar Ganesan
CEO | Chief Executive Officer | 69 | 15-03-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 1,312 | -0.36% | 72 593 |
24-04-18 | 1,316 | +0.02% | 102,719 |
24-04-16 | 1,316 | +1.20% | 128,852 |
24-04-15 | 1,301 | +0.57% | 78,919 |
24-04-12 | 1,293 | -1.47% | 70,151 |
Delayed Quote NSE India S.E., April 19, 2024 at 07:43 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.91% | 43.54B | |
+16.96% | 21.74B | |
+7.61% | 13.53B | |
+7.98% | 13.02B | |
+33.80% | 11.28B | |
-11.05% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.71% | 5.09B |
- Stock Market
- Equities
- CAPLIPOINT Stock
- CAPLIPOINT Stock